Search Results - "LIEBER, Andre"
-
1
Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival
Published in Proceedings of the National Academy of Sciences - PNAS (01-10-2013)“…Most current cancer therapies focus on killing malignant cells, but these cells are often genetically unstable and can become resistant to chemotherapy…”
Get full text
Journal Article -
2
An Engineered Virus Library as a Resource for the Spectrum-wide Exploration of Virus and Vector Diversity
Published in Cell reports (Cambridge) (23-05-2017)“…Adenoviruses (Ads) are large human-pathogenic double-stranded DNA (dsDNA) viruses presenting an enormous natural diversity associated with a broad variety of…”
Get full text
Journal Article -
3
Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1
Published in Proceedings of the National Academy of Sciences - PNAS (24-11-2009)“…In the recently halted HIV type 1 (HIV-1) vaccine STEP trial, individuals that were seropositive for adenovirus serotype 5 (Ad5) showed increased rates of…”
Get full text
Journal Article -
4
Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes
Published in Blood (15-10-2006)“…Upon local delivery, adenovirus (Ad) serotype 5 viruses use the coxsackie and Ad receptor (CAR) for cell binding and αv integrins for internalization. When…”
Get full text
Journal Article -
5
Adenovirus vectors in hematopoietic stem cell genome editing
Published in FEBS letters (01-12-2019)“…Genome editing of hematopoietic stem cells (HSCs) represents a therapeutic option for a number of hematological genetic diseases, as HSCs have the potential…”
Get full text
Journal Article -
6
CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy
Published in Oncoimmunology (03-10-2018)“…Dendritic cells (DCs) are crucial players in promoting immune responses. Logically, adoptive DC therapy is a promising approach in cancer immunotherapy. One of…”
Get full text
Journal Article -
7
P317: Gene therapy base editors reshape single-molecule chromatin architecture of γ-globin promoters
Published in Genetics in Medicine Open (2023)Get full text
Journal Article -
8
Directed evolution generates a novel oncolytic virus for the treatment of colon cancer
Published in PloS one (18-06-2008)“…Viral-mediated oncolysis is a novel cancer therapeutic approach with the potential to be more effective and less toxic than current therapies due to the agents…”
Get full text
Journal Article -
9
Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors
Published in Blood (14-10-2010)“…A major limitation for adenoviral transduction in vivo is the profound liver tropism of adenovirus type 5 (Ad5). Recently, we demonstrated that coagulation…”
Get full text
Journal Article -
10
Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy
Published in Oncoimmunology (01-02-2017)“…Vaccination with dendritic cells (DCs), the most potent professional antigen-presenting cells in the body, is a promising approach in cancer immunotherapy…”
Get full text
Journal Article -
11
Discovery of Novel Methylation Biomarkers in Cervical Carcinoma by Global Demethylation and Microarray Analysis
Published in Cancer epidemiology, biomarkers & prevention (01-01-2006)“…A genome-wide screening study for identification of hypermethylated genes in invasive cervical cancer (ICC) was carried out to augment our previously…”
Get full text
Journal Article -
12
In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model
Published in Molecular therapy (03-02-2021)“…We have recently reported that, after in vivo hematopoietic stem cell/progenitor (HSPC) transduction with HDAd5/35++ vectors, SB100x transposase-mediated…”
Get full text
Journal Article -
13
Two types of functionally distinct fiber containing structural protein complexes are produced during infection of adenovirus serotype 5
Published in PloS one (27-02-2015)“…Adenoviruses are common pathogens. The localization of their receptors coxsackievirus and adenovirus receptor, and desmoglein-2 in cell-cell junction complexes…”
Get full text
Journal Article -
14
Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy
Published in Oncotarget (28-02-2015)“…Oncolytic gene therapy using viral vectors may provide an attractive therapeutic option for malignant gliomas. These viral vectors are designed in a way to…”
Get full text
Journal Article -
15
Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity
Published in Journal of Virology (01-06-2005)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
16
CryoEM structure of adenovirus type 3 fibre with desmoglein 2 shows an unusual mode of receptor engagement
Published in Nature communications (12-03-2019)“…Attachment of human adenovirus (HAd) to the host cell is a critical step of infection. Initial attachment occurs via the adenoviral fibre knob protein and a…”
Get full text
Journal Article -
17
Prospects and challenges of in vivo hematopoietic stem cell genome editing for hemoglobinopathies
Published in Molecular therapy (04-10-2023)Get full text
Journal Article -
18
Quantification of designer nuclease induced mutation rates: a direct comparison of different methods
Published in Molecular therapy. Methods & clinical development (01-01-2016)“…Designer nucleases are broadly applied to induce site-specific DNA double-strand breaks (DSB) in genomic DNA. These are repaired by nonhomologous end joining…”
Get full text
Journal Article -
19
Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing
Published in Blood (28-06-2018)“…Disorders involving β-globin gene mutations, primarily β-thalassemia and sickle cell disease, represent a major target for hematopoietic stem/progenitor cell…”
Get full text
Journal Article -
20
CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells
Published in Cancer biology & therapy (31-12-2024)“…Multiple myeloma (MM) is an incurable malignancy of the B-cell lineage. Remarkable progress has been made in the treatment of MM with anti-CD38 monoclonal…”
Get full text
Journal Article